Clinical Trials Browser

Phase 2 × Kidney Neoplasms × Panitumumab × Clear all

NCT00425035 2013-05-13

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

Phase 2 Completed

Kidney Neoplasms